AI assistant
Sending…
Nuvalent, Inc. — Director's Dealing 2022
Aug 2, 2022
30903_dirs_2022-08-02_2070f09d-9eec-42e7-a7df-f95db04c73ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2022-08-01
Reporting Person: Noci Darlene (Chief Development Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-01 | Stock Option (Right to Buy) | $14.40 | A | 50000 | Acquired | 2032-08-01 | Class A Common Stock (50000) | Direct |
Footnotes
F1: The shares underlying this option vest as follows: 25% of the shares vest on August 1, 2023, and the remainder vest over the next three years in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
More from Nuvalent, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 7
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Annual Report
2026
Feb 26